IMRAN QURESHI

TEMPLE, TX

This page merges CMS profile IDs: 11429546, 11553359 (associated profiles published by CMS for the same provider; see the provenance section below).

General Payments — all program years on this page

$1,202.08

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 34
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $766.98 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $583.7515
Travel and Lodging $160.834
Education $22.401

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Nevro Corp. $298.175
Amgen Inc. $247.439
Ipsen Biopharmaceuticals, Inc $132.272
Medtronic, Inc. $45.872
ABBVIE INC. $22.701
Merz Pharmaceuticals, LLC $20.541

By program year

Program yearAmountRecords
2022 $22.141
2023 $412.9613
2024 $766.9820

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1091954577 Ipsen Biopharmaceuticals, Inc $10.91 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091954579 Ipsen Biopharmaceuticals, Inc $121.36 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105339748 ABBVIE INC. $22.70 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681292 Amgen Inc. $29.55 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681294 Amgen Inc. $31.14 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681296 Amgen Inc. $32.03 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681298 Amgen Inc. $26.84 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681300 Amgen Inc. $30.67 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681302 Amgen Inc. $25.90 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681304 Amgen Inc. $29.14 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681306 Amgen Inc. $19.10 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111681308 Amgen Inc. $23.06 12/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119329523 Medtronic, Inc. $23.47 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119329525 Medtronic, Inc. $22.40 04/02/2024 Education Undisputed 01/23/2026 View at CMS
1130781674 Nevro Corp. $9.57 09/29/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1130781676 Nevro Corp. $0.30 10/01/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1130781678 Nevro Corp. $72.42 09/30/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1130781818 Nevro Corp. $78.54 09/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1130781880 Nevro Corp. $137.34 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137949768 Merz Pharmaceuticals, LLC $20.54 05/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
  • Merged CMS profile IDs: 11429546, 11553359

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.